2026 NPPES data Hospitalist Physician NPI 1508062993 MD
Verify on CMS →

MARK BRIDENSTINE, MD

Hospitalist Physician in LONGMONT, Colorado. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 535 beneficiaries · Hospitalist Physician avg: 888
Generic prescribing
49%
generic claims · 51% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$82.02
5 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK BRIDENSTINE, MD is a Hospitalist Physician ([object Object]) practicing in LONGMONT, Colorado with a Medicare Part D prescribing footprint of 3K claims across 535 beneficiaries — 51% brand-name prescribing . Industry payments of $82.02 across 5 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MARK BRIDENSTINE, MD filed 2,884 Medicare Part D claims in 2023 across LONGMONT, Colorado. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

MARK BRIDENSTINE, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK BRIDENSTINE, MD at a glance

Quality data not reported

NPI registry status

Active

Issued 06/22/2007

NPI 1508062993

Primary specialty

Hospitalist Physician

Mid-sized

16,825 US NPIs in this specialty

Medicare Part D claims

2,884 225% vs specialty avg

2023 prescription claims

Specialty avg: 888

Specialty distribution in Colorado

How Hospitalist Physician compares to other specialties among Colorado providers

Colorado providers

Hospitalist Physician share within Colorado

1. Hospitalist Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hospitalist Physician share within Colorado

Specialty board-certification context

Estimated specialty board-certified rate — Hospitalist Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hospitalist Physician ABMS/AOA estimate

Est. board-certified rate (Hospitalist Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hospitalist Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK BRIDENSTINE, MD is a Hospitalist Physician provider practicing in LONGMONT, Colorado, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1508062993. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK BRIDENSTINE, MD appears in the CMS NPPES registry as a Hospitalist Physician provider holding MD credentials at 1925 MOUNTAIN VIEW AVE, LONGMONT, CO, 80501, with a listed phone of (720) 494-3119. NPI 1508062993 was issued on 06/22/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BRIDENSTINE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,884 prescription claims written by this provider, covering 535 Medicare beneficiaries and totaling roughly $2.3 million in drug spend, split 51% brand-name and 49% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hospitalist Physician is a mid-sized specialty nationwide, with 16,825 enrolled providers across 54 states and an average of 888 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1925 MOUNTAIN VIEW AVE
LONGMONT, CO 80501

Provider Details

NPI 1508062993
Specialty Hospitalist Physician
Credentials MD
Gender Male
NPI Issued 06/22/2007

Hospital and facility affiliations

Facilities where MARK BRIDENSTINE, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

POUDRE VALLEY MEDICAL GROUP LLC
LONGMONT, CO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK BRIDENSTINE, MD. Source: openpaymentsdata.cms.gov.

Total received

$82

Largest payer

Bayer Healthcare Pharmaceuticals Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

MARK BRIDENSTINE, MD — brand share 51.0%
Specialty average (est.)

51% brand-name claims vs 49% generic, on 2,884 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,884
Total Claims
$2.3M
Total Drug Cost
535
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,837
Total Day Supply
203,467
Brand vs Generic
51% brand / 49% generic
Brand Drug Cost
$2.2M
Generic Drug Cost
$35K

Patient Demographics

Average Patient Age
69.9 years
Avg HCC Risk Score
1.67
Gender Split
60% female / 40% male
Age Distribution
<65: 100, 65-74: 266, 75-84: 149, 85+: 20

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
360
Metformin Hcl Er
Metformin Hcl
147
Tresiba Flextouch U-200
Insulin Degludec
134
Ozempic
Semaglutide
118
Jardiance
Empagliflozin
114
Metformin Hcl
110
Trulicity
Dulaglutide
108
Novolog Flexpen
Insulin Aspart
71
Tresiba Flextouch U-100
Insulin Degludec
70
Humalog Kwikpen U-100
Insulin Lispro
68

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hospitalist Physician Overview

How MARK BRIDENSTINE, MD fits within the Hospitalist Physician landscape nationally.

16,825
Hospitalist Physician Providers in US
54
States with Hospitalist Physician
888
Avg Claims per Provider

MARK BRIDENSTINE, MD's 2,884 claims are above the specialty average of 888.

Nearby Hospitalist Physician Providers in Colorado

Other clinicians with the same primary specialty enrolled in Colorado, drawn from the same CMS NPPES roster as BRIDENSTINE.

Compare Hospitalist Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK BRIDENSTINE, MD's specialty?
MARK BRIDENSTINE, MD specializes in Hospitalist Physician and practices in LONGMONT, Colorado. Credentials: MD.
How much does MARK BRIDENSTINE, MD prescribe under Medicare Part D?
In 2023, MARK BRIDENSTINE, MD wrote 2,884 Medicare Part D claims totaling $2.3M in drug costs for 535 beneficiaries.
Where is MARK BRIDENSTINE, MD located?
MARK BRIDENSTINE, MD is located at 1925 MOUNTAIN VIEW AVE, LONGMONT, CO, 80501. Phone: (720) 494-3119.
What is MARK BRIDENSTINE, MD's NPI number?
MARK BRIDENSTINE, MD's National Provider Identifier (NPI) is 1508062993, issued on 06/22/2007.
Does MARK BRIDENSTINE, MD prescribe more brand-name or generic drugs?
MARK BRIDENSTINE, MD's prescribing is 51% brand-name and 49% generic drugs by claim count, with $2.2M in brand drug costs.
How many Hospitalist Physician providers are there in the US?
There are 16,825 Hospitalist Physician providers across 54 states in the US. The average Hospitalist Physician provider writes 888 Medicare Part D claims per year.
What drugs does MARK BRIDENSTINE, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK BRIDENSTINE, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl Er, Tresiba Flextouch U-200. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK BRIDENSTINE, MD accept Medicare?
MARK BRIDENSTINE, MD appears in CMS Medicare data with 2,884 Part D claims and 535 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK BRIDENSTINE, MD's credentials?
MARK BRIDENSTINE, MD's NPI is 1508062993 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology